- Home
- Clinical Trials
Atopic Dermatitis Study Dunedin Evo
Atopic Dermatitis Study
Dunedin
Are you struggling with widespread, moderate to severe eczema? Are you interested in helping researchers find a better potential treatment?
This study is exploring a potential new medicine that aims to ease eczema symptoms by suppressing skin inflammation.
The study medicine will be given intravenously (IV) which is a way to deliver the medication directly into the bloodstream using a drip.
Description
What to expect
Study details
Ages
18 years or older
Duration
Approximately 16 weeks which will include 6 scheduled visits to the clinic
Compensation
Eligible participants will be compensated
Eligibility Criteria
To join this study, here’s what we’re looking for
- You need to be 18 years or older.
- Have had widespread, moderate to severe eczema for at least six months before your first screening visit. The study doctor will assess this for you.
- You should be in generally good health.
Other exclusion criteria will apply.
Locations
Description
Atopic dermatitis, also known as eczema, is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.
Flare ups of symptoms can be caused by a wide range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it more susceptible to irritants.
Current treatments include topical creams and corticosteroids, but these options don’t always provide lasting relief so there is a need for more effective treatment.
What to expect
Momentum is conducting a clinical research study exploring a potential new medicine designed to ease eczema symptoms by suppressing skin inflammation.
The study medicine will be given intravenously (IV) which is a way to deliver the medication directly into the bloodstream using a drip. This is a placebo controlled study so some participants will receive a non-active investigational medicine and some participants will receive the active investigational medicine.
The study will focus on understanding how effective the investigational medicine is in easing eczema symptoms. Regular assessments will be conducted to monitor eczema symptoms while on the investigational medicine.
The main ethical aspects of this study have been approved by Northern B HDEC, ETHICS REF 2024 FULL 21709.
Register your interest now to find out if you are eligible to participate and if this study is a good fit for you.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.